|
End-of-day quote
Shenzhen S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 12.26 CNY | +0.66% |
|
+0.16% | -14.62% |
| Market Cap | 3.58B 533M 474M 442M 403M 760M 51.28B 767M 5.35B 2.07B 26.21B 2B 1.96B 84.13B | P/E 2024 |
23.5x | P/E 2025 | 37.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2.94B 439M 390M 364M 332M 626M 42.19B 631M 4.4B 1.71B 21.57B 1.65B 1.61B 69.22B | EV / Sales 2024 |
0.18x | EV / Sales 2025 | 0.18x |
| Free-Float |
56.83% | Yield 2024 |
1.32% | Yield 2025 | 0.8% |
| 1 day | +0.66% | ||
| 1 week | +0.16% | ||
| 1 month | -0.24% | ||
| 3 months | +7.92% | ||
| 6 months | -14.39% | ||
| Current year | -14.62% |
| 1 week | 12.15 |  | 12.31 |
| 1 month | 11.88 | | 12.6 |
| Current year | 10.57 | | 19.69 |
| 1 year | 10.57 | | 19.69 |
| 3 years | 9.78 | | 19.69 |
| 5 years | 9.78 | | 20.7 |
| 10 years | 9.78 | | 43.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Bin Huang
PSD | President | 55 | 2021-08-11 |
Jun Lin
PRN | Corporate Officer/Principal | 57 | 2022-11-08 |
Wei Gao
PRN | Corporate Officer/Principal | 54 | 2019-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Cui Na Jing
BRD | Director/Board Member | 42 | 2009-07-23 |
Wen Li Xu
CHM | Chairman | 60 | 2015-09-14 |
Xue Tian Dong
BRD | Director/Board Member | 37 | 2015-09-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.66% | +0.16% | -10.97% | -13.42% | 533M | |
| -0.61% | -3.43% | +36.07% | +115.04% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.63% | 617B | |
| +1.11% | -0.58% | +12.36% | +77.95% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.24% | 356B | |
| -0.95% | -4.05% | +20.54% | +41.71% | 333B | |
| -1.46% | -2.89% | +10.57% | +32.81% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.98% | 244B | |
| -1.04% | -2.79% | +35.30% | +51.84% | 218B | |
| -1.87% | -4.10% | +28.44% | +93.66% | 179B | |
| Average | -0.62% | -3.23% | +22.37% | +51.44% | 369.77B | |
| Weighted average by Cap. | -0.60% | -3.54% | +29.07% | +70.55% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 24.02B 3.58B 3.18B 2.97B 2.71B 5.11B 344B 5.15B 35.95B 13.93B 176B 13.45B 13.16B 565B | 19.53B 2.91B 2.59B 2.41B 2.2B 4.15B 280B 4.19B 29.22B 11.32B 143B 10.93B 10.7B 459B |
| Net income | 161M 23.96M 21.29M 19.87M 18.11M 34.16M 2.3B 34.48M 240M 93.19M 1.18B 89.97M 88.02M 3.78B | 111M 16.61M 14.76M 13.78M 12.56M 23.68M 1.6B 23.9M 167M 64.6M 816M 62.37M 61.02M 2.62B |
| Net Debt | 642M 95.81M 85.13M 79.45M 72.42M 137M 9.21B 138M 961M 373M 4.71B 360M 352M 15.11B | -634M -94.53M -83.99M -78.39M -71.45M -135M -9.09B -136M -949M -368M -4.65B -355M -347M -14.91B |
Employees
1,741
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | CN¥12.26 | +0.66% | 1,770,400 |
| 26-09-29 | CN¥12.18 | -0.49% | 1,822,500 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- 002462 Stock
Select your edition
All financial news and data tailored to specific country editions
